FindTrial
Sign In

Coronary stent

DEVICE9 trials

Sponsors

Cook Group Incorporated, European Hospital, San Giuseppe Moscati Hospital, ECRI bv, Henry Ford Health System

Conditions

3 Vessel Coronary Artery DiseaseAngina PectorisCardiovascular DiseasesChronic Kidney DiseaseCoronary Artery DiseaseCoronary Artery StenosisCoronary AtherosclerosisHeart Diseases

Phase 2

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease
CompletedNCT00818792
European HospitalChronic Kidney Disease, Multivessel Coronary Artery Disease
Start: 2009-01-31End: 2012-09-30Updated: 2013-01-15

Phase 3

Everolimus Stent in Patients With Coronary Artery Disease (CAD)
CompletedNCT01182649
San Giuseppe Moscati HospitalCoronary Artery Disease, Coronary Atherosclerosis
Start: 2007-03-31End: 2010-06-30Updated: 2010-08-17

Unknown Phase

The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial
CompletedNCT00196079
Cook Group IncorporatedCoronary Artery Disease
Start: 2000-02-29End: 2001-08-31Target: 177Updated: 2012-02-01
The ELUTES Clinical Trial
CompletedNCT00225654
Cook Group IncorporatedCoronary Artery Disease
Start: 2000-01-31End: 2001-11-30Target: 192Updated: 2012-02-01
Trial Evaluating New Strategy in the Functional Assessment of 3-vessel Disease Using SYNTAXII Score in Patients With PCI
CompletedNCT02015832
ECRI bv3 Vessel Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases
Start: 2014-02-06End: 2021-02-04Updated: 2022-07-21
Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI
TerminatedNCT02499666
Henry Ford Health SystemAngina Pectoris, Coronary Artery Disease
Start: 2015-06-29End: 2017-10-30Updated: 2022-03-07
Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study
CompletedNCT02759406
Palmaz ScientificIschemic Heart Disease
Start: 2013-09-30End: 2015-06-30Updated: 2016-05-03
BIOTRONIK Orsiro Pre-Marketing Registration
CompletedNCT02870985
Biotronik (Beijing) Medical Device Ltd.Coronary Artery Disease
Start: 2015-07-14End: 2021-12-31Updated: 2024-03-04
To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
Not yet recruitingNCT07098195
Poly Medicure LimitedCoronary Artery Disease, Coronary Artery Stenosis, de Novo Lesions in Native Coronary Arteries +1
Start: 2025-08-18End: 2028-01-17Target: 2000Updated: 2025-08-01

Related Papers

Comparison of Clinically Adjudicated Versus Flow-Based Adjudication of Revascularization Events in Randomized Controlled Trials
Circulation Cardiovascular Quality and Outcomes2021-10-208 citations
Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial.
2020-04-0514 citations
Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD.
2018-05-2291 citations
Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using instantaneous wave-free ratio.
2018-01-314 citations
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
European Heart Journal2017-08-23289 citations
Bypass Grafting Versus Percutaneous Intervention-Which Is Better in Multivessel Coronary Disease: Lessons From SYNTAX and Beyond.
2015-10-317 citations
Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) Study
Circulation2013-12-2036 citations